Streptomyces cinnamonensis produces the polyether ionophore antibiotic monensin A. Following a single round of mutagenesis by UVlight, a derivative of this strain has been isolated, which secretes a new metabolite identified as 26-deoxymonensin A (3). The structural elucidation of the newmetabolite followed from a spectroscopic analysis, and its identity was proven conclusively following a comparison to 26-deoxymonensin A (3) obtained synthetically from monensin A. The preparation of labelled forms of 3 is described, together with incorporation experiments using the parent strain of S. cinnamonensis. Only very low levels of incorporation of 3 into monensin A were observed.Monensin A (1) is an important polyether ionophore antibiotic, produced13 by Streptomyces cinnamonensis. The biosynthesis of this antibiotic has attracted a great deal of interest2~5), following proposals3»4) that the cyclic ether groups in monensin A might arise by the novel mechanism shown in Scheme1, proceeding via a cascade of cyclisation steps on a triepoxide intermediate. This route is supported by the results of isotope labelling experiments3~5) that define the biosynthetic origins of the carbon and oxygen atoms in monensin A, and similar experiments with other polyethers, including narasin6), lenoremycin7), lasalocid A8), ICI 1396039) and maduramicin10), strengthen a belief that this very appealing concept may be applied generally10 to account for the formation of cyclic ether rings in manyof the other knownmembersof this family of secondary metabolites.In order to further characterize the pathway to the monensins A (1) and B (2) in S. cinnamonensis, we have generated mutants blocked in monensin production, and describe here the isolation of one such mutant that accumulates mainly 26-deoxymonensin A (3); the mutant must carry a lesion in the hydroxylation step occuring at the terminal C-26 position. The structure assigned to 3 has been confirmed by direct comparison with a sample of 26-deoxymonensin A prepared chemically from monensin A.There have been no other reports, to date, on the isolation of mutants specifically blocked in the monensin biosynthetic pathway. Also, no hona fide biosynthetic intermediates have been isolated, although 3-0-demethylmonensins A (4) and B have been recovered12-* as minor components from the fermentation broth of a normal producing strain.